Controversies in the management of ovarian cancer

被引：2
|
作者：
Ozols, RF
机构：
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 1997年 / 7卷
关键词：
cisplatin-cyclophosphamide; cytoreductive surgery; dose intensity; intraperitoneal chemotherapy; new standard chemotherapy; paclitaxel-cisplatin; whole abdomen irradiation;
D O I：
10.1046/j.1525-1438.7.s1.4.x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A new standard chemotherapy for ovarian cancer has been accepted in the USA: paclitaxel (Taxol(R)) plus a platinum compound (cisplatin or carboplatin). There remain, however, many areas of controversy in treating this disease, including the role of cytoreductive surgery, the optimum combination regimen, the approach to managing patients who achieve a clinical remission, the importance of dose intensity in chemotherapy, the efficacy of intraperitoneal therapy, the benefit of whole-abdomen irradiation, and the status of immunotherapy and hormones.
引用
收藏
页码：27 / 32
页数：6
相关论文
共 50 条
  • [1] Controversies in the Management of Advanced Ovarian Cancer
    Khanna, Namita
    Horowitz, Ira R.
    ONCOLOGY-NEW YORK, 2011, 25 (10): : 934 - +
  • [2] Ovarian cancer: progress and continuing controversies in management
    Moss, C
    Kaye, SB
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (13) : 1701 - 1707
  • [3] Challenges and controversies in the conservative management of uterine and ovarian cancer
    Janda, M.
    McGrath, S.
    Obermair, A.
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2019, 55 : 93 - 108
  • [4] Remaining controversies in the upfront management of advanced ovarian cancer
    Mano, MS
    Awada, A
    Minisini, A
    Atalay, G
    Lago, LD
    Cardoso, F
    Piccart, M
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (05) : 707 - 720
  • [5] Controversies in the Management of Ovarian Cancer - Pros and Cons for Lymph Node Dissection in Ovarian Cancer
    Camara, Oumar
    Sehouli, Jalid
    ANTICANCER RESEARCH, 2009, 29 (07) : 2837 - 2843
  • [6] Controversies in ovarian cancer - Reply
    Spirtos, N
    Eisenkop, S
    Schlaerth, J
    Ballon, S
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (06) : 1310 - 1311
  • [7] CONTROVERSIES IN THE MANAGEMENT OF OVARIAN CANCER PRO AND CONS OF INTRAPERITONEAL (IP) CHEMOTHERAPY
    Zeimet, Alain G.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3551 - 3551
  • [8] Controversies in the Management of Epithelial Ovarian Cancers
    Saif, Ayesha
    Nadeem, Nighat
    Rizwan, Wajiha
    Durrani, Humaira
    Azeem, Maryam
    Shami, Nabeela
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2020, 14 (04): : 832 - 834
  • [9] Controversies in surgical management of advanced ovarian cancer (Stage III-IV)
    Makar, AP
    Kisic, J
    Tropé, CG
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2000, 21 (05) : 449 - 460
  • [10] Controversies in the management of serous borderline tumors and low-grade serous ovarian cancer
    Ilenkovan, Narthana
    Ryan, Neil
    Roxburgh, Patricia
    Bell, Sarah
    Gourley, Charlie
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2025, 35 (03)
12345